General Information
Drug ID
DR01266
Drug Name
Naloxegol
Synonyms
NKTR-118
Drug Type
Small molecular drug
Indication Opioid-induced constipation [ICD11: ME05.0] Approved [1]
Structure
3D MOL 2D MOL
Formula
C34H53NO11
Canonical SMILES
COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O
InChI
InChI=1S/C34H53NO11/c1-3-9-35-10-8-33-30-26-4-5-27(36)31(30)46-32(33)28(6-7-34(33,37)29(35)25-26)45-24-23-44-22-21-43-20-19-42-18-17-41-16-15-40-14-13-39-12-11-38-2/h3-5,28-29,32,36-37H,1,6-25H2,2H3/t28-,29+,32-,33-,34+/m0/s1
InChIKey
XNKCCCKFOQNXKV-ZRSCBOBOSA-N
CAS Number
CAS 854601-70-0
Pharmaceutical Properties Molecular Weight 651.8 Topological Polar Surface Area 127
Heavy Atom Count 46 Rotatable Bond Count 24
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 12
XLogP
-1
PubChem CID
56959087
PubChem SID
162108769 , 163326055 , 172232572 , 187051840 , 198945150 , 223447656
ChEBI ID
CHEBI:82975
TTD Drug ID
D07LCF
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Naloxegol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Tarascon Pocket Pharmacopoeia 2018 Classic Shirt-Pocket Edition.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.